Literature DB >> 7668912

Serum levels of interleukin-8 in patients with Behcet's disease.

K Ozoran, O Aydintuğ, G Tokgöz, N Düzgün, H Tutkak, A Gürler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7668912      PMCID： PMC1009949          DOI： 10.1136/ard.54.7.610

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Clinical features of Behçet's disease. Report of four cases.

Authors:  T N Helm; C Camisa; C Allen; C Lowder
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1991-07

2.  Skin hyperreactivity response (pathergy) in Behçet's disease.

Authors:  A Gilhar; G Winterstein; H Turani; J Landau; A Etzioni
Journal:  J Am Acad Dermatol       Date:  1989-09       Impact factor: 11.527

3.  Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Authors:  F M Brennan; C O Zachariae; D Chantry; C G Larsen; M Turner; R N Maini; K Matsushima; M Feldmann
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

4.  Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease.

Authors:  K Hamzaoui; K Ayed; A Slim; M Hamza; J Touraine
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

5.  Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis.

Authors:  P Peichl; M Ceska; H Broell; F Effenberger; I J Lindley
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

6.  Localisation of interleukin 8 in the synovial membrane, cartilage-pannus junction and chondrocytes in rheumatoid arthritis.

Authors:  B Deleuran; P Lemche; M Kristensen; C Q Chu; M Field; J Jensen; K Matsushima; K Stengaard-Pedersen
Journal:  Scand J Rheumatol       Date:  1994       Impact factor: 3.641

7.  Elevated serum levels of IL-8 in patients with HIV infection.

Authors:  T Matsumoto; T Miike; R P Nelson; W L Trudeau; R F Lockey; J Yodoi
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330
  7 in total
  6 in total

1.  Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.

Authors:  Sho Ueda; Mitsuteru Akahoshi; Atsunobu Takeda; Yasushi Inoue; Aya Omoto; Masahiro Ayano; Yasutaka Kimoto; Hiroki Mitoma; Yojiro Arinobu; Hiroaki Niiro; Hiroshi Tsukamoto; Takahiko Horiuchi; Shin-Ichi Hikita; Takako Fukuhara; Tatsuro Ishibashi; Koh-Hei Sonoda; Koichi Akashi
Journal:  Eur J Rheumatol       Date:  2018-03

2.  Plasma and whole-blood chemokine levels in patients with Behcet's disease.

Authors:  Toshikatsu Kaburaki; Yujiro Fujino; Hidetoshi Kawashima; Guillermo Merino; Jiro Numaga; Jun Chen; Kouji Matsushima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-23       Impact factor: 3.117

3.  Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: A Pilot Study.

Authors:  Eun Chun Han; Sung Bin Cho; Keun Jae Ahn; Sang Ho Oh; Jihyun Kim; Dong Soo Kim; Kwang Hoon Lee; Dongsik Bang
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

4.  Behcet's disease and cardiovascular involvement: our experience of asymptomatic Behcet's patients.

Authors:  Zeynep Ulusan; Ayse Serap Karadag; Mehmet Tasar; Mehmet Kalender; Osman Tansel Darcin
Journal:  Cardiovasc J Afr       Date:  2014 Mar-Apr       Impact factor: 1.167

5.  Serum level of Interleukin-8 in subjects with diabetes, diabetes plus oral lichen planus, and oral lichen planus: A biochemical study.

Authors:  Atefeh Tavangar; Faezeh Khozeimeh; Fereshtehossadat Ghoreishian; Mahsa Abbasi Boroujeni
Journal:  Dent Res J (Isfahan)       Date:  2016-09

6.  Behcet's Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8.

Authors:  Hao Yin; Yun Song; Meimei Zheng; Ju Han; Jiyou Tang
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.